Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 1/20 | 0.39 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.37 |
| ▸ | PPARG | P37231 | 2/20 | 0.35 |
| ▸ | KDM1A | O60341 | 2/20 | 0.35 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.35 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.34 |
| ▸ | CCKAR | P32238 | 4/20 | 0.34 |
| ▸ | CCKBR | P32239 | 4/20 | 0.34 |
| ▸ | GUCY1B2 | O75343 | 2/20 | 0.33 |
| ▸ | GUCY1A2 | P33402 | 2/20 | 0.33 |
| ▸ | GUCY1A1 | Q02108 | 2/20 | 0.33 |
| ▸ | GUCY1B1 | Q02153 | 2/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6709839 | 0.98 | XDH (0.37) | XDHPTGER1PPARGKDM1AGRIK1 | |
| SCHEMBL6711788 | 0.96 | KDM1A (0.36) | XDHPTGER1PPARGKDM1AGRIK1 | |
| SCHEMBL6708861 | 0.91 | XDH (0.39) | XDHPTGER1PPARGKDM1AGRIK1 | |
| SCHEMBL6711633 | 0.91 | ALDH1A1 (0.35) | GRIK1GRM5IRAK4 | |
| SCHEMBL6708788 | 0.90 | XDH (0.39) | XDHPPARGKDM1ARCOR1CCKAR | |
| SCHEMBL6710047 | 0.89 | GRIK1 (0.37) | XDHPTGER1PPARGKDM1AGRIK1 | |
| SCHEMBL6707700 | 0.88 | KDM1A (0.38) | XDHPPARGKDM1ARCOR1 | |
| SCHEMBL6713869 | 0.88 | GRIK1 (0.38) | PTGER1PPARGKDM1AGRIK1RCOR1 | |
| SCHEMBL6710118 | 0.87 | GRIK1 (0.37) | PPARGKDM1AGRIK1RCOR1CCKAR | |
| SCHEMBL6709918 | 0.87 | GRIK1 (0.38) | GRIK1GRM5BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | GABRD, PHB1, GABBR1 | XDH 142/4885PTGER1 3857/4885PPARG 262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.